HLA-A*0201 & B2M & EBV LMP1 (YLLEMLWRL)

HLA-A*0201 & B2M & EBV LMP1 (YLLEMLWRL) Produktliste

Attribut
Protein (2)
Produktbibliothek
Online (2)
Spezies
Human (2)
Etikett
His Tag & Avi Tag (1)His Tag (1)
Marker
Biotin-labeled (1)PE Labeled (1)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Proteinstruktur	Reinheit	Eigenschaften	Vorbestellen/Bestellen
HLP-H82Ec	Human	HEK293	Biotinylated Human HLA-A*02:01&B2M&EBV LMP1 (YLLEMLWRL) Complex Protein (Monomer, MALS verified)				In den Warenkorb legen
HLP-HP2Hd	Human	HEK293	PE-Labeled Human HLA-A*02:01&B2M&EBV LMP1 (YLLEMLWRL) Tetramer Protein				In den Warenkorb legen

Gesamtmenge2

HLA-A*0201 & B2M & EBV LMP1 (YLLEMLWRL) Molekülhintergrund

Epstein-Bar Virus (EBV), also known as human herpesvirus 4, belongs to gamma herpes virus family and is a very common human virus worldwide. EBV causes infectious mononucleosis (IM) and also associates to some specific types of cancers such as Burkitt’s lymphoma (BL) and gastric carcinoma (GC). Glycoprotein B (gB) plays an important role in viral entry by binding with αvβ6/αvβ8 integrins to trigger the membrane fusion and entry process of epithelial cells, which makes it become an great target for EBV research. Epstein-Bar Virus (EBV), also known as human herpesvirus 4, belongs to gamma herpes virus family and is a very common human virus worldwide. EBV causes infectious mononucleosis (IM) and also associates to some specific types of cancers such as Burkitt’s lymphoma (BL) and gastric carcinoma (GC). Glycoprotein B (gB) plays an important role in viral entry by binding with αvβ6/αvβ8 integrins to trigger the membrane fusion and entry process of epithelial cells, which makes it become an great target for EBV research. The Human HLA-A*0201 EBV LMP1 (YLLEMLWRL) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M and YLLEMLWRL peptide of the EBV LMP1.

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
NGM-313	NGM-313; MK-3655	Phase 2 Clinical	Ngm Biopharmaceuticals Inc	Metabolic Dysfunction-Associated Steatotic Liver Disease; Hepatitis; Obesity	Details
Fazpilodemab	RG-7992; BFKB-8488A; RO-7040551	Phase 1 Clinical	Genentech Inc	Metabolic Dysfunction-Associated Steatotic Liver Disease; Diabetes Mellitus, Type 2; Insulin Resistance	Details
B-1344	B-1344	Phase 1 Clinical	Tasly Biomedical Co Ltd	Metabolic Dysfunction-Associated Steatotic Liver Disease; Diabetes Mellitus, Type 2	Details